Concepedia

Todd Hembrough

TH

45

Publications

4.4K

Citations

30

H-Index

1995

Active since

Affiliations

OncoPlex Diagnostics (United States)(Current)

University of Chicago

Memorial Sloan Kettering Cancer Center

Cornell University

CASI Pharmaceuticals (United States)

Todd Hembrough is an author at OncoPlex Diagnostics (United States) specializing in medicine, cancer research, and tumor biology.

Top concepts

Publications per year

1995–2020

45

Publications

45

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 541 citations

, , +14

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine et al. · Nature · 2017 · 540 citations

, , +12

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Qu Zhang, Jia Luo, Song Wu et al. · Cancer Discovery · 2020 · 323 citations · Full text

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Gabrielle S. Wong, Jin Zhou, Jie Bin Liu et al. · Nature Medicine · 2018 · 268 citations · Full text

, , +9

Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

Todd Hembrough, Glenn M. Swartz, Adonia E. Papathanassiu et al. · PubMed · 2003 · 197 citations

, , +19

Rows per page

1–5 of 45